ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,827.04
-1.54%
Dow Jones
41,938.45
-1.63%
US Dollar vs MXN
20.7181
0.00%
Brent Oil
79.285
0.00%
Bitcoin
94,529.67
-0.19%
Pepperstone
Advertisement
Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ

  6. Oncocyte Corporation (OCX) Cotización

Oncocyte Corporation

Oncocyte Corporation (OCX)

NASDAQ
2.21
-0.02
(-0.90%)
Cerrado 10 Enero 3:00PM
Delayed by 15 minutes
2.21
0.00
(0.00%)
Fuera de horario: 5:44PM
Delayed by 15 minutes

Su centro para precios en tiempo real, ideas y debates en vivo

Premium

Estadísticas y detalles clave

Último Precio
2.21
Postura de Compra
2.10
Postura de Venta
2.48
Volume Operado de la Acción
8,211
2.13 Rango del Día 2.32
1.97 Rango de 52 semanas 3.5687
Capitalización de Mercado [m]
37.206M
Precio Anterior
2.23
Precio de Apertura
2.22
Hora
60
@
2.21
Última hora de negociación
Volumen financiero
US$ 18,344
Precio Promedio Ponderado
2.2341
Volumen promedio (3 m)
89,510
Acciones en circulación
16,835,247
Rendimiento del Dividendo
-
Ratio Precio/Utilidad
-1.30
Beneficio por acción (BPA)
-1.71
turnover
7.27M
Beneficio neto
-28.72M

Acerca de Oncocyte Corporation

OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers.... OncoCyte Corp focuses on the discovery, development, and commercialization of novel, non-invasive, liquid biopsy diagnostics for the early detection of cancer. The company develops diagnostic tests based on liquid biopsies using blood or urine samples for detecting lung, bladder, and breast cancers. In addition, it also develops screening diagnostics as potential replacements for screening imaging procedures that do not meet the needs of patients, health care providers or payers. Geographically operation of the group is carried through the United States, and it earns revenue from the sale of diagnostic tests. Mostrar más

Sector
In Vitro,in Vivo Diagnostics
Industria
In Vitro,in Vivo Diagnostics
Sitio web
www.oncocyte.com
Sede
Irvine, California, USA
Fundado
-
Oncocyte Corporation is listed in the In Vitro,in Vivo Diagnostics sector of the NASDAQ with ticker OCX. The last closing price for Oncocyte was US$2.23. Over the last year, Oncocyte shares have traded in a share price range of US$ 1.97 to US$ 3.5687.

Oncocyte currently has 16,835,247 shares in issue. The market capitalisation of Oncocyte is US$37.54 million. Oncocyte has a price to earnings ratio (PE ratio) of -1.30.

OCX Últimas noticias

Más noticias

Form 8-K - Current report

08 Enero 2025
Edgar (US Regulatory)

Oncocyte Appoints Dr. Paul Billings as Consulting Chief Medical Officer

Dr. Billings is a renowned diagnostics specialist with a history of commercializing novel assays in precision medicineWill provide key regulatory and reimbursement supportWill assist business...

08 Enero 2025
GlobeNewswire Inc.

Oncocyte Expands Market Opportunity for VitaGraft™ Kidney

Medicare coverage expanded following study showing that monitoring with Oncocyte’s assay significantly reduces time to rejection diagnosis in patients with newly developed donor-specific...

06 Enero 2025
GlobeNewswire Inc.

Oncocyte to Participate in “J.P. Morgan Week” and Host Investor Meetings

IRVINE, Calif., Dec. 09, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp., (Nasdaq: OCX), a leading diagnostics technology company, today announced that Chief Executive Officer Josh Riggs and Chief...

09 Diciembre 2024
GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities

09 Diciembre 2024
Edgar (US Regulatory)

Oncocyte Demonstrates Potential for Liquid Biopsy of Brain Tumors in New Study

IRVINE, Calif., Dec. 04, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp. (NASDAQ: OCX), a diagnostics technology company, today announced the publication of favorable data regarding its...

04 Diciembre 2024
GlobeNewswire Inc.

Oncocyte dd-cfDNA Assay Detects Kidney Transplant Rejection 11+ Months Ahead of Standard Protocols, New Study Affirms 

Oncocyte first to published randomized interventional data to rule-in for biopsy in high-risk patient population Study shows that monitoring with Oncocyte’s assay significantly reduces time to...

02 Diciembre 2024
GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

12 Noviembre 2024
Edgar (US Regulatory)

Form 8-K - Current report

12 Noviembre 2024
Edgar (US Regulatory)

Oncocyte Reports Commercial Launch Progress; On Track to Sign 20 Transplant Centers by End of 2025

Transplant centers representing about 9% of German transplant volumes and about 2% of U.S. transplant volumes have signed on to use GraftAssure kitted research test in early launch phaseFDA...

12 Noviembre 2024
GlobeNewswire Inc.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
1-0.16-6.751054852322.372.44992.18231702.28427784CS
4-0.27-10.88709677422.482.691.97727182.26787838CS
12-0.91-29.16666666673.123.21.97895102.52336473CS
26-0.76-25.58922558922.973.47991.97537992.68878695CS
52-1.1-33.23262839883.313.56871.97483672.73082397CS
156-38.79-94.60975609764145.21.9723331914.80632715CS
260-67.59-96.833810888369.81251.9730749843.36029311CS

OCX - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Oncocyte?
El precio actual de las acciones de Oncocyte es US$ 2.21
¿Cuántas acciones de Oncocyte están en circulación?
Oncocyte tiene 16,835,247 acciones en circulación
¿Cuál es la capitalización de mercado de Oncocyte?
La capitalización de mercado de Oncocyte es USD 37.54M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Oncocyte?
Oncocyte ha negociado en un rango de US$ 1.97 a US$ 3.5687 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Oncocyte?
El ratio precio/beneficio de Oncocyte es -1.3
¿Cuál es el ratio de efectivo a ventas de Oncocyte?
El ratio de efectivo a ventas de Oncocyte es 5.12
¿Cuál es la moneda de reporte de Oncocyte?
Oncocyte presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Oncocyte?
El último ingresos anual de Oncocyte es USD 7.27M
¿Cuál es el último beneficio anual de Oncocyte?
El último beneficio anual de Oncocyte es USD -28.72M
¿Cuál es la dirección registrada de Oncocyte?
La dirección registrada de Oncocyte es 15 CUSHING, IRVINE, CALIFORNIA, 92618
¿Cuál es la dirección del sitio web de Oncocyte?
La dirección del sitio web de Oncocyte es www.oncocyte.com
¿En qué sector industrial opera Oncocyte?
Oncocyte opera en el sector IN VITRO,IN VIVO DIAGNOSTICS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
VRMEVerifyMe Inc
US$ 2.57
(52.98%)
57.69M
WKEYWISeKey International Holdings AG
US$ 10.041
(52.83%)
6.68M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.49M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.16B
INTZIntrusion Inc
US$ 2.8888
(44.44%)
40.44M
IGMSIGM Biosciences Inc
US$ 2.095
(-66.21%)
5.8M
CDTGCDT Environmental Technology Investment Holdings Ltd
US$ 1.87
(-51.30%)
2.28M
MODVModivCare Inc
US$ 6.51
(-47.88%)
2.73M
AIFUAIX Inc
US$ 0.420501
(-47.76%)
7.85M
MRSNMersana Therapeutics Inc
US$ 0.691
(-46.85%)
58.44M
CDTConduit Pharmaceuticals Inc
US$ 0.1214
(48.05%)
1.17B
NVDANVIDIA Corporation
US$ 135.91
(-3.00%)
207.47M
RGTIRigetti Computing Inc
US$ 8.9299
(-11.06%)
178.69M
VMARVision Marine Technologies Inc
US$ 2.14
(40.79%)
175.55M
DATSDatChat Inc
US$ 4.8105
(49.86%)
158.58M

Discusión

Ver feed completo
extrinsic55 extrinsic55 3 minutos hace
SGBX ask .59 ClimbingChartItCollectingEOD
SGBX
aBeezlee aBeezlee 3 minutos hace
People keep talking about RS online... Is there even a filing? I feel like it's bs.
SVMH
kBletsgo30 kBletsgo30 4 minutos hace
Annoying as hell 
RSPI
extrinsic55 extrinsic55 4 minutos hace
SGBX ask .59 ClimbingChartItCollectingEOD
SGBX
DesertDrifter DesertDrifter 4 minutos hace
Most new cars do not even have a spare, not even an emergency donut.   Found this out in a Ford with a sidewall cut out of cell range.  All it had was a little pump, useless on a cut tire.
extrinsic55 extrinsic55 4 minutos hace
SGBX ask .59 ClimbingChartItCollecting
SGBX
Gaseous Clay Gaseous Clay 5 minutos hace
I find it incredible and perplexing that a company that has produced, what, $20k in revenue over its 25-year existence has over 200k posts devoted to it on the this board. As someone in this industry, I’ve followed this company with a mix of bewilderment and horror at its continued existence, contin
LWLG
Explosivo Explosivo 5 minutos hace
Funny how all the dumpers are old? Depends should be a sponsor for this board, right?
HMBL
kenjiroo kenjiroo 5 minutos hace
Nahh He Sure got a point !!! ST3 never updated his shareholders … deadlines if …. Duhhhhh VuMe app ??? Kinda start believing You got payed per post !!! VuMe Will NEVER be launhed …. Nothing more then dropping kilo’s at dropping harbour !!! Sjees …’we have protocol
TPTW
kenjiroo kenjiroo 5 minutos hace
Nahh He Sure got a point !!! ST3 never updated his shareholders … deadlines if …. Duhhhhh VuMe app ??? Kinda start believing You got payed per post !!! VuMe Will NEVER be launhed …. Nothing more then dropping kilo’s at dropping harbour !!! Sjees …’we have protocol
TPTW
CanItBThisEZ2Make CanItBThisEZ2Make 5 minutos hace
A Buyout Would be Really Bad News. If any company was to buy out SRMX it would be TCL for $0.0010 per share . Is that all you want for your shares❓


GO SRMX(TCCI)$
SRMX
Spuds McKenz66 Spuds McKenz66 6 minutos hace
hey Aka missing in action Happy New Year , will pick some up next week MLGO
MLGO
jay_tee jay_tee 6 minutos hace
Let's pretend you're not at the corner liquor store picking up another bottle to cope....Hopefully one day we could celebrate together with the good stuff! Leave that Eand J mad dog tj samuels wild
Turkey Taaka vodka etc... alone! We are too old for that! lol 
RNVA
fung_derf fung_derf 6 minutos hace
ok. I'll take your word for it. I don't want to debate minutae
Whalatane Whalatane 6 minutos hace
Well there is the patent cliff and BP is looking for new assets ...UNCY is unlikely launch their drug themselves


Biogen proposes to buy remaining stake in Sage in $442 million deal

Kiwi
UNCY
Clark6290 Clark6290 7 minutos hace
Shoot, if you read posts here, these Ballers on this board have way more than 115M commons. 🤔

Don't believe any posts here, do your own research and be cautious.
FNMA
jimr1717 jimr1717 7 minutos hace
Tesla Model S and Model X owners affected by the ongoing wildfires in CA are thanking the electric car maker once more for their vehicles’ Bioweapon Defense Mode, which allows passengers to breathe clean air inside the cabin despite hazardous air conditions outside.

The state of CA i
TSLA
Whalatane Whalatane 7 minutos hace
Well there is the patent cliff and BP is looking for new assets ...RZLT unlikely launch their drug themselves


Biogen proposes to buy remaining stake in Sage in $442 million deal

Kiwi
RZLT
Vexari Vexari 8 minutos hace
Create a problem

Time reaction

Solve problem

Media controls

The agenda

Who controls

The media

Getting

Close
PFE
AKATITUS AKATITUS 8 minutos hace
Got find the new landing zone first.
😄
MLGO
RickNagra RickNagra 8 minutos hace
https://youtu.be/lQgdbs0UIF4
FNMA
Moonboy1 Moonboy1 10 minutos hace
Awesome after hrs close tonight. Heading back up next week?
TNXP
surfkast surfkast 10 minutos hace
Pathological hatred for scammers. George wants to remind his minions that he went from 14 ponies to over 100 thanks to them. Not to mention needing at least $4 million a year to run his stable. He again was short at least $3 million last year! 😭
WNFT
ergo sum ergo sum 11 minutos hace
Why do you have to always bring personal attack?

That is the weakest way to make a point.
williamssc williamssc 11 minutos hace
After several meetings EMA requested we apply for full approval. Followed by EMA excepted our application. Seems the only thing defective is the shorts plan.
AVXL

Su Consulta Reciente

NASDAQ
OCX
Oncocyte
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2025 ADVFN PLC - Todos los derechos reservados